Literature DB >> 25332317

Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.

Jin Ho Hwang1, Ho Jun Chin2, Sejoong Kim2, Dong Ki Kim3, Suhnggwon Kim3, Jung Hwan Park4, Sung Joon Shin5, Sang Ho Lee6, Bum Soon Choi7, Chun Soo Lim8.   

Abstract

BACKGROUND AND OBJECTIVES: The antiproteinuric effect of a renin-angiotensin-aldosterone system blockade can be magnified by dietary salt restriction. This study sought to determine the effect of intensive low-salt diet education on BP and urine albumin excretion in nondiabetic patients with hypertension and albuminuria. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study was conducted between March of 2012 and March of 2013 as an open-label, randomized, controlled trial. After a run-in period of 8 weeks, all patients received the angiotensin II receptor blocker olmesartan (40 mg daily). Patients were then divided into two groups. One group was treated for another 8 weeks with angiotensin II receptor blocker plus conventional low-salt diet education, and the other group was treated for 8 weeks with angiotensin II receptor blocker plus intensive low-salt diet education. The final analyses was performed with 245 completed patients.
RESULTS: The amount of daily albuminuria was significantly decreased from 0 (566.0 [25.0-5398.6] mg/d) to 8 weeks (282.5 [16.1-4898.5] mg/d; P<0.001). From 8 to 16 weeks, the 24-hour urinary sodium excretion was decreased by 36.0±5.9 mmol/d in the intensive education group and 8.8±4.9 mmol/d in the conventional education group (interaction P<0.001). Patients who completed intensive low-salt diet education exhibited greater decreases in urinary albumin excretion than the control group (change in albuminuria from 8 to 16 weeks, -154.0 versus 0.4 mg/d; P=0.01). Urinary albumin excretion tended to decrease as the 24-hour urinary sodium excretion amount decreased (R=0.32; 95% confidence interval, 0.20 to 0.43; P<0.001).
CONCLUSIONS: The 24-hour urinary albumin excretion was decreased more in patients in the intensive low-salt diet education group than patients in the conventional education group. Weekly intensive education on a low-salt diet would be a suitable method for clinical practice.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; albuminuria; angiotensin system; hypertension; nutrition; rennin

Mesh:

Substances:

Year:  2014        PMID: 25332317      PMCID: PMC4255393          DOI: 10.2215/CJN.01310214

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  26 in total

1.  Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.

Authors:  Hiddo J Lambers Heerspink; Frank A Holtkamp; Hans-Henrik Parving; Gerjan J Navis; Julia B Lewis; Eberhard Ritz; Pieter A de Graeff; Dick de Zeeuw
Journal:  Kidney Int       Date:  2012-03-21       Impact factor: 10.612

2.  Sodium intake, ACE inhibition, and progression to ESRD.

Authors:  Stefan Vegter; Annalisa Perna; Maarten J Postma; Gerjan Navis; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

3.  Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.

Authors:  F Locatelli; D Marcelli; M Comelli; D Alberti; G Graziani; G Buccianti; B Redaelli; A Giangrande
Journal:  Nephrol Dial Transplant       Date:  1996-03       Impact factor: 5.992

4.  The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial.

Authors:  P R Conlin; D Chow; E R Miller; L P Svetkey; P H Lin; D W Harsha; T J Moore; F M Sacks; L J Appel
Journal:  Am J Hypertens       Date:  2000-09       Impact factor: 2.689

5.  Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.

Authors:  T J Allen; M J Waldron; D Casley; G Jerums; M E Cooper
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials.

Authors:  J M Geleijnse; F J Kok; D E Grobbee
Journal:  J Hum Hypertens       Date:  2003-07       Impact factor: 3.012

9.  How far should salt intake be reduced?

Authors:  Feng J He; Graham A MacGregor
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

10.  [Prediction of 24-hour urinary creatinine excretion from age, body weight and height of an individual and its application].

Authors:  T Kawasaki; K Uezono; K Itoh; M Ueno
Journal:  Nihon Koshu Eisei Zasshi       Date:  1991-08
View more
  20 in total

1.  Remote Dietary Counseling Using Smartphone Applications in Patients With Stages 1-3a Chronic Kidney Disease: A Mixed Methods Feasibility Study.

Authors:  Alex R Chang; Lisa Bailey-Davis; Vonda Hetherington; Anna Ziegler; Christina Yule; Sara Kwiecen; Elisabeth Graboski; Melissa M Melough; Charlotte Collins; Cheryl Anderson
Journal:  J Ren Nutr       Date:  2019-05-08       Impact factor: 3.655

2.  Diet and Chronic Kidney Disease.

Authors:  Holly Kramer
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

3.  Effects of Dietary App-Supported Tele-Counseling on Sodium Intake, Diet Quality, and Blood Pressure in Patients With Diabetes and Kidney Disease.

Authors:  Sarah J Schrauben; Apurva Inamdar; Christina Yule; Sara Kwiecien; Caitlin Krekel; Charlotte Collins; Cheryl Anderson; Lisa Bailey-Davis; Alex R Chang
Journal:  J Ren Nutr       Date:  2021-10-11       Impact factor: 3.655

Review 4.  Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review.

Authors:  Sarah J Schrauben; Benjamin J Apple; Alex R Chang
Journal:  Kidney360       Date:  2022-01-14

Review 5.  Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects.

Authors:  Samuel J Jurca; William J Elliott
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

Review 6.  Salt-induced effects on microvascular function: A critical factor in hypertension mediated organ damage.

Authors:  Maria E Marketou; Spyros Maragkoudakis; Ioannis Anastasiou; Helen Nakou; Marina Plataki; Panos E Vardas; Fragiskos I Parthenakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-19       Impact factor: 3.738

7.  Interventions for weight loss in people with chronic kidney disease who are overweight or obese.

Authors:  Marguerite M Conley; Catherine M McFarlane; David W Johnson; Jaimon T Kelly; Katrina L Campbell; Helen L MacLaughlin
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

Review 8.  The Science of Salt: A Systematic Review of Quality Clinical Salt Outcome Studies June 2014 to May 2015.

Authors:  Claire Johnson; Thout Sudhir Raj; Kathy Trieu; JoAnne Arcand; Michelle M Y Wong; Rachael McLean; Alexander Leung; Norm R C Campbell; Jacqui Webster
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

9.  Altered dietary salt intake for people with chronic kidney disease.

Authors:  Emma J McMahon; Katrina L Campbell; Judith D Bauer; David W Mudge; Jaimon T Kelly
Journal:  Cochrane Database Syst Rev       Date:  2021-06-24

10.  Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial.

Authors:  Seung Seok Han; Eunjin Bae; Shin Young Ahn; Sejoong Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Ho Jun Chin; Chun Soo Lim; Suhnggwon Kim; Dong Ki Kim
Journal:  BMC Nephrol       Date:  2015-08-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.